Condition: Tuberculosis (TB) · Sponsor: International AIDS Vaccine Initiative
A Phase 2b, double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety and immunogenicity of a candidate tuberculosis (TB) vaccine, MTBVAC, against TB disease in adolescents and adults aged 14-45 years, living in a TB endemic region.
This description comes directly from the study's public registry record.
Elana Van Brakel, MD · 27.21.344.1200 · evanbrakel@iavi.org
Ansuya Naidoo, MBChB · +27724152138 · ANaidoo@iavi.org
Always discuss trial participation with your own doctor first.
| Victoria Biomedical Research Institute | Kisumu, Kenya | Recruiting |
| Kenya Medical Research Institute | Nairobi, Kenya | Recruiting |
| JOSHA Research | Bloemfontein, South Africa | Recruiting |
| South African Tuberculosis Vaccine Initiative | Cape Town, South Africa | Recruiting |
| TASK Applied Science Pty Ltd. TASK Delft | Cape Town, South Africa | Recruiting |
| UCTLI CLII - Centre for Lung Infection and Immunity | Cape Town, South Africa | Recruiting |
| University of Cape Town Lung Institute PtyLtd. Centre for Tuberculosis Research Innovation | Cape Town, South Africa | Recruiting |
| Wellcome Centre for Infectious Diseases Research in Africa | Cape Town, South Africa | Recruiting |
| Synergy Biomedical Research Institute | East London, South Africa | Recruiting |
| TASK Eden Pty Ltd. | George, South Africa | Recruiting |
| Perinatal HIV Research Unit | Johannesburg, South Africa | Recruiting |
| Be Part Research Pty Ltd. | Paarl, South Africa | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06272812